PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.71%
Negative net income growth while CNQ stands at 1.39%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
17.57%
D&A growth well above CNQ's 9.26%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
80.68%
Lower deferred tax growth vs. CNQ's 556.02%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-720.43%
Negative yoy working capital usage while CNQ is 61.70%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-162.94%
Negative yoy while CNQ is 172.51%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-45.29%
Negative yoy CFO while CNQ is 34.82%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
21.44%
CapEx growth well above CNQ's 17.30%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-641.12%
Both yoy lines negative, with CNQ at -207.07%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-226.89%
Both yoy lines negative, with CNQ at -7.37%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2582.77%
We cut debt repayment yoy while CNQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.20%
Both yoy lines negative, with CNQ at -30.46%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
94.45%
Buyback growth of 94.45% while CNQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.